FF
HAE icon

FourThought Financial’s Haemonetics HAE Stock Holding History

FourThought Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$82K Hold
1,113
– – 0.01% 479
2022
Q2 		$73K Buy
1,113
+96
+9% +$5.68K 0.01% 513
2022
Q1 		$64K Buy
1,017
+96
+10% +$5.22K 0.01% 592
2021
Q4 		$49K Hold
921
– – 0.01% 673
2021
Q3 		$65K Buy
921
+508
+123% +$32.1K 0.01% 613
2021
Q2 		$27K Sell
413
-12
-3% -$849 ﹤0.01% 869
2021
Q1 		$47K Sell
425
-28
-6% -$3.46K 0.01% 702
2020
Q4 		$53K Buy
+453
New +$48.8K 0.01% 649

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FourThought Financial's HAE Position: Q3 2022 in Review

FourThought Financial held its Haemonetics (HAE) position steady in Q3 2022 at 1,113 shares worth $82K. The position accounts for 0.01% of the portfolio, ranked #479.

FourThought Financial first reported a position in HAE in Q4 2020 and has held it in 8 quarters since. 270 funds tracked by Wall St. Rank hold HAE as of Q3 2022.

  • FourThought Financial held 1,113 shares of Haemonetics worth $82K as of Q3 2022.
  • FourThought Financial left its Haemonetics share count unchanged in Q3 2022.
  • Haemonetics made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #479 holding.
  • FourThought Financial first reported a position in Haemonetics in Q4 2020 and has held it in 8 quarters since.
  • 270 funds tracked by Wall St. Rank held Haemonetics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.